 |
| AGENDA July 23, 2001 4:00 pm-7:00 pm Registration 6:00 pm-7:00 pm Opening Reception (open bar and hors d'oeuvres) 7:00 pm-8:30 pm Dinner Dinner Speaker: Hugo W. Moser, MD, Kennedy Krieger Institute and Johns Hopkins University School of Medicine, Baltimore, Maryland "Emerging Therapies for Neurologic Disorders" (panelists do not attend the dinner) Evening Session: Verbal Apraxia: Current Thoughts Chair: Marilyn Agin, MD 8:30 pm-8:40 pm Opening and Welcoming Remarks Marilyn Agin, MD and Ms. Lisa Geng 8:40 pm-9:10 pm "Verbal Apraxia: The Perspective of a Developmental Pediatrician" Marilyn Agin, MD 9:10 pm-9:40 pm "Verbal Apraxia: The Perspective of a Speech Therapist" Nancy Kaufman, MA, CCC-SLP 9:40 p.m.-10:10 p.m. Discussion All Panelists 10:10 pm. Adjourn July 24, 2001 7:00 am-8:00 am Registration Morning Session: Essential Fatty Acids (EFAs) and the Brain Chairs: Susan E. Carlson, Ph.D. and Robert Katz, Ph.D. 8:00 am-8:30 am Welcome and Introduction: "What are EFAs? Susan E. Carlson, PhD and Robert Katz, PhD * Each presentation includes a 5-minute Question and Answer period. 8:30 am-9:00 am "Psychiatric Consequences of Omega-3 Fatty Acid Insufficiency" Joseph Hibbeln, MD 9:00 am-9:30 am "Omega-3 Fatty Acids in Neuropsychological Disorders" Andrew L. Stoll, MD 9:30 am-9:50 am Coffee Break 9:50 am-10:20 am "EFA Supplementation Trials in Premature Babies and Infants" Susan E. Carlson, Ph.D. 10:20 am-10:50 am "Therapeutic Trials in Autism Spectrum Disorders" Andrew Zimmerman, MD 10:50 am-11:30 am "EFAs as Potential Therapeutic Agents in Verbal Apraxia: Analysis of Professional Anecdotal Case Reports" Marilyn Agin, MD, Lori Roth, MA, CCC-SLP and Robert Katz, PhD 11:30 am-12:15 am Roundtable Discussion:"Are Clinical Studies/Trials of EFA Supplementation in Verbal Apraxia Timely and Justified?" All Panel Members 12:15 am-1:00 pm Lunch Afternoon Session: Verbal Apraxia; Possible Clinical Studies/Trials Chairs: Andrew Zimmerman, MD and Andrew L. Stoll, MD 1:00 pm-1:10 pm "Clinical Tools for the Assessment of the Apraxic Child" Lori Roth, MA, CCC-SLP 1:10 pm-1:20 pm "Fatty Acid Profiles: Markers of EFA Status" Ann Moser 1:20 pm-1:30 pm "Neurobehavioral Markers" Andrew Zimmerman, MD 1:30 pm-1:40 pm "Neurophysiological Measures of Cognitive & Motorical Development During Early Infancy" Jennifer Hill-Karrer, PhD 1:40 pm-2:40 pm "Designing EFA Supplementation Studies/Trials for Verbal Apraxia" All Panel Members 2:40 pm-3:00 pm Coffee Break Closing Session: Summary and Recommendations Chairs: Andrew Zimmerman, MD, and Lori Roth, MA, CCC-SLP 3:00 pm-3:30 pm Discussion of the Planned Clinical Research, Formulation of Recommendations and Closing Remarks All Panel Members 3:30 pm- Adjourn |
| C.H.E.R.A.B. Foundation Emergency Fact-Finding Workshop on "Essential Fatty Acids and Verbal Apraxia: A New Potential Therapeutic Intervention" July 23-24, 2001, Headquarters Plaza Hotel, Morristown, New Jersey |